ProGen Life Sciences Overview
- Founded
-
2001
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
ProGen Life Sciences General Information
Description
Developer of diagnostic biomarkers designed to guide physicians in choosing the most effective therapeutic approach. The company's diagnostic biomarkers include treatment regimens for various cancer based on the expression of molecular biomarkers and can guide physicians in choosing the most effective therapeutic approach, enabling oncologists to guide using proprietary tests and optimizing the therapeutic regimens available for cancer patients.
Contact Information
Website
www.progenlifesciences.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
- 25 Health Science Drive
- Stony Brook, NY 11790
- United States
+1 (949) 000-0000
ProGen Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
ProGen Life Sciences Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mohan Chellani Ph.D | Founder & President |
ProGen Life Sciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Long Island High Technology Incubator | Accelerator/Incubator | 000 0000 | 000000 0 |